Babesiosis: Difference between revisions

Line 40: Line 40:


=Sources=
=Sources=
<references/>
*CDC http://www.cdc.gov/parasites/babesiosis/
*CDC http://www.cdc.gov/parasites/babesiosis/


[[Category:ID]]
[[Category:ID]]

Revision as of 15:04, 4 June 2015

Background

  • Spread by the deer tick (Ixodes scapularis)
    • People often unaware they are bitten
  • Natural reservior is the white footed mouse
  • Endemic in US, Europe, parts of Russia and China
    • Babesia Microti is pathogen in US

Symptoms

Diagnosis

  • Peripheral blood smear
    • Shows intracellular parasites
      • Maltese Cross sign
    • May need large smear as parasitemia can be as low as 1%
    • Can often be confused for malaria parasites

Differential Diagnosis

Tick Borne Illnesses

Management

  • 2 drug regimen for 7-10 days

Option 1

  • Atovaquone (750mg BID) and Azithromycin (500-1000mg on first day, 250-1000mg on subsequent days)

Option 2

Clindamycin

  • 600 mg PO q8h x 7-10 days
  • Alt: 300-600mg IV q6h x 7-10 days
    • First Dose: 300-600mg IV x 1
  • Give with Quinine (650mg TID); use IV for severe infections

Pediatrics

  • Clindamycin 20 mg/kg/day for children and 25 mg/kg/day for children for 7-10 days

Treatment Failure

  • Atovaquone 750 mg q12 and azithromycin 500 mg on day 1 and 250 mg/day x 7 days[1]

See Also

Sources

  1. Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR 3rd, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. Nov 16 2000;343(20):1454-8.